Global Stem Cell Treatments for Cancer Market 2022
Cancer stem cells (CSCs) are responsible for carcinogenesis and tumorigenesis and are involved in drug and radiation resistance, metastasis, tumor relapse and initiation. According to a report by StrategyHelix, the global stem cell treatments for cancer market is set to increase by US$ 2,209.6 million during 2022-2028, growing at a CAGR of 11.8% during the forecast period. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the stem cell treatments for cancer market to help drive informed decision making for industry executives, policy makers, academic, and analysts.